KOPRAN.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 18:59):

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally...

Stats
本日の出来高	187 549
平均出来高	443 209
時価総額	11.65B
EPS	INR0 ( 2024-02-06 )
次の収益日	( INR0 ) 2024-05-23
Last Dividend	INR3.00 ( 2023-09-07 )
Next Dividend	INR0 ( N/A )
P/E	28.89
ATR14	INR0.443 (0.18%)

ボリューム相関

長: 0.06 (neutral)

短: 0.71 (moderate)

Signal:(61.007) Neutral

Kopran Limited 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Kopran Limited 相関 - 通貨/商品

-0.45
( neutral )

-0.59
( weak negative )

-0.38
( neutral )

-0.41
( neutral )

0.20
( neutral )

-0.09
( neutral )

Kopran Limited 財務諸表

Annual	2022
収益:	INR5.51B
総利益:	INR1.92B (34.92 %)
EPS:	INR5.65

FY	2022
収益:	INR5.51B
総利益:	INR1.92B (34.92 %)
EPS:	INR5.65

FY	2022
収益:	INR4.74B
総利益:	INR1.90B (40.10 %)
EPS:	INR13.77

FY	2021
収益:	INR4.81B
総利益:	INR1.67B (34.72 %)
EPS:	INR14.24

Financial Reports:

No articles found.

Kopran Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR3.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR3.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Kopran Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.83 - low (27.53%) | Divividend Growth Potential Score: 3.05 - Decrease likely (39.08%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.500	2020-11-05
Last Dividend	INR3.00	2023-09-07
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	INR9.00	--
Avg. Dividend % Per Year	1.18%	--
Score	2.05	--
Div. Sustainability Score	3.83
Div.Growth Potential Score	3.05
Div. Directional Score	3.44	--

Next Divdend (Est)
(2024-05-20)

INR3.25 Estimate 3.08 %

Dividend Stability

0.25 Very Poor

Dividend Score

2.05

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2020	INR1.500	4.82%
2021	INR1.500	1.08%
2022	INR3.00	0.91%
2023	INR3.00	2.01%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TFCILTD.NS	Dividend Junior	2023-08-11	Annually	23	1.38%
ORIENTBELL.NS	No Dividend Player	2023-07-18	Annually	18	0.14%
IRCON.NS	Dividend Knight	2023-09-05	Semi-Annually	6	3.39%
CROMPTON.NS	Dividend Junior	2023-07-06	Annually	8	0.52%
SHIVALIK.NS	Dividend Junior	2023-09-22	Annually	3	0.03%
MANORAMA.NS	Dividend Junior	2023-09-11	Insufficient data to determine frequency	2	0.07%
GRAVITA.NS	Dividend Junior	2023-09-04	Annually	14	0.72%
BAJAJHLDNG.NS	Dividend Knight	2023-09-29	Annually	22	1.20%
UBL.NS	Dividend Junior	2023-08-03	Annually	17	0.27%
POLYCAB.NS	Dividend Knight	2023-06-21	Annually	6	0.50%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0697	1.500	8.61	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0917	1.500	-0.0923	-0.139	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	7.54	1.000	8.32	8.32	[3 - 30]
operatingCashFlowPerShareTTM	8.79	2.00	7.07	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.38	2.00	8.31	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.356	1.000	7.40	7.40	[0.2 - 0.8]
operatingProfitMarginTTM	0.101	1.000	9.97	9.97	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.83

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	28.96	1.000	7.18	0	[1 - 100]
returnOnEquityTTM	0.0917	2.50	-0.0594	-0.139	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.38	2.00	8.87	10.00	[0 - 30]
dividendYielPercentageTTM	1.237	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.79	2.00	7.07	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0895	1.500	-3.93	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0732	1.000	-0.670	0	[0.1 - 0.5]
Total Score				3.05

Kopran Limited

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, dry powder, suspension, and injectables. It also provides active pharmaceutical ingredients in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. The company was incorporated in 1958 and is headquartered in Mumbai, India.